ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Chronic respiratory disease,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
3,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
4,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
5,1,Immunosuppressant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
6,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
7,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
